Literature DB >> 24646338

Dietary advices on carbohydrate intake for pregnant women with type 1 diabetes.

Ann B Roskjær1, Jens Rikardt Andersen, Helle Ronneby, Peter Damm, Elisabeth R Mathiesen.   

Abstract

The impact of the quality and quantity of carbohydrate intake on glycaemic control and pregnancy outcome was evaluated with focus on pregnant women with type 1 diabetes. For women with type 1 diabetes, a gestational weight gain within the lower range of the guidelines of the Institute of Medicine (IOM) is generally recommended. A low-glycaemic index diet is considered safe, and has shown, positive effects on the glycaemic control and pregnancy outcomes for both healthy women, those with type 2 diabetic and gestational diabetes (GDM). In general, carbohydrate counting does improve glycaemic control in type 1 diabetes. A moderately low carbohydrate diet with a carbohydrate content of 40% of the calories results in better glycaemic control and comparable obstetric outcomes in type 2 diabetes and GDM when compared to a diet with a higher carbohydrate content, and is regarded safe in diabetic pregnancy. In type 1 diabetes pregnancy, a moderately low carbohydrate diet with 40% carbohydrates has been suggested; however, a minimum intake of 175 g carbohydrate daily is recommended. Despite limited evidence the combination of a low-glycaemic index diet with a moderately low carbohydrate intake, using carbohydrate counting can be recommended for pregnant women with type 1 diabetes.

Entities:  

Keywords:  Carbohydrate; carbohydrate counting; glycaemic index; low-carbohydrate-diet; pregnancy; type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 24646338     DOI: 10.3109/14767058.2014.906577

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  4 in total

Review 1.  Improving pregnancy outcomes in women with diabetes mellitus: modern management.

Authors:  Lene Ringholm; Peter Damm; Elisabeth R Mathiesen
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

2.  CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial.

Authors:  Sidse Kjærhus Nørgaard; Elisabeth Reinhardt Mathiesen; Kirsten Nørgaard; Tine Dalsgaard Clausen; Peter Damm; Lene Ringholm
Journal:  BMJ Open       Date:  2021-04-09       Impact factor: 2.692

3.  Zone-MPC Automated Insulin Delivery Algorithm Tuned for Pregnancy Complicated by Type 1 Diabetes.

Authors:  Basak Ozaslan; Sunil Deshpande; Francis J Doyle; Eyal Dassau
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-22       Impact factor: 5.555

4.  Effect of motivational interviewing on gestational weight gain and fetal growth in pregnant women with type 2 diabetes.

Authors:  Björg Ásbjörnsdóttir; Marianne Vestgaard; Lene Ringholm; Lise Lotte Torvin Andersen; Dorte Møller Jensen; Peter Damm; Elisabeth R Mathiesen
Journal:  BMJ Open Diabetes Res Care       Date:  2019-11-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.